Location History:
- Holsbeek, BE (2007)
- Ghent, BE (2008)
Company Filing History:
Years Active: 2007-2008
Title: Gert Verheyden: Innovator in HCV Envelope Proteins
Introduction
Gert Verheyden is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of virology, particularly in the development of hepatitis C virus (HCV) envelope proteins. With a total of two patents to his name, Verheyden's work is crucial for diagnostic and therapeutic advancements.
Latest Patents
Verheyden's latest patents include "HCV E1 comprising specific disulfide bridges" and "Core-glycosylated HCV envelope proteins." The first patent relates to recombinantly or synthetically produced HCV E1 envelope proteins that include disulfides between specific cysteine residues. This invention also encompasses viral-like particles and compositions that utilize these proteins, along with methods and kits for their application. The second patent focuses on HCV envelope proteins that are expressed in eukaryotic cells, characterized by a high percentage of core-glycosylation at their N-glycosylation sites. These proteins are particularly valuable for diagnostic, prophylactic, and therapeutic purposes.
Career Highlights
Gert Verheyden has been instrumental in advancing the understanding of HCV envelope proteins. His innovative approaches have led to significant breakthroughs in the field, enhancing the potential for effective treatments and diagnostics for hepatitis C.
Collaborations
Verheyden has collaborated with notable colleagues such as Erik Depla and Fons Bosman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Gert Verheyden's contributions to the field of virology, particularly through his patents on HCV envelope proteins, highlight his role as a key innovator. His work continues to pave the way for advancements in the diagnosis and treatment of hepatitis C.